20/20 Biolabs Inc. (AIDX) vs Gelteq Limited Ordinary Shares (GELS)

A side-by-side comparison of 20/20 Biolabs Inc. and Gelteq Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
20/20 Biolabs Inc. logo
AIDX
20/20 Biolabs Inc.
$4M
$0.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Gelteq Limited Ordinary Shares logo
GELS
Gelteq Limited Ordinary Shares
$5M
$0.58HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — AIDX vs GELS

growth of $100 · dividends reinvested · last 1y
AIDX -98.5% (-98.5%/yr)GELS -28.5% (-28.5%/yr)GELS compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100$1$71
AIDX GELS

AIDX vs GELS: by the numbers

  • •GELS is the larger company ($5M vs $4M market cap).
  • •Both run net losses; AIDX's is the smaller (-285.00% vs -4011.86% net margin).

Metrics side by side

Valuation

MetricAIDXGELS
P/S ratio2.12N/A
P/B ratio2.660.56

Profitability

MetricAIDXGELS
Gross margin31.52%100.00%
Operating margin-162.87%-3317.65%
Net margin-285.00%-4011.86%
ROE-184.04%-42.05%
ROIC-116.89%-27.41%

Growth (annualized)

MetricAIDXGELS
Revenue CAGR (5Y)-2.58%N/A

Go deeper

Full AIDX analysisFull GELS analysisInteractive comparison tool

Dig into the metrics

20/20 Biolabs ROEGelteq Limited Ordinary Shares ROE20/20 Biolabs operating marginGelteq Limited Ordinary Shares operating margin20/20 Biolabs revenue growthGelteq Limited Ordinary Shares revenue growth20/20 Biolabs free cash flowGelteq Limited Ordinary Shares free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.